9 employees
GILUPI is a Germany-based company that develops medical devices for the in vivo isolation of rare cells out of circulating blood.
2006
$4.8M
from 5 investors over 5 rounds
GILUPI GmbH raised $4.8M on January 13, 2011
Investors: BC Brandenburg Capital, KfW, Brandenburg Kapital GmbH, High-Tech Gründerfonds and Aurelia Private Equity GmbH